Clinical Trials
0
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
News
Medical Horizons Partners with Bowhead Health to Expand AI-Powered Clinical Trial Matching Across Italy, Turkey, and Cyprus
Medical Horizons S.r.l. has secured an exclusive distribution agreement with Canadian company Bowhead Health Inc. to bring AI-powered clinical trial matching technology to Italy, Turkey, and Cyprus.
RadNet to Acquire iCAD for $100 Million, Advancing AI-Powered Breast Cancer Detection
RadNet Inc. has announced plans to acquire iCAD Inc. for approximately $100 million, uniting two leading companies in AI-powered cancer detection technology with a focus on breast cancer screening.
iCAD and Koios Medical Unite to Launch Comprehensive AI-Powered Breast Cancer Detection Platform
iCAD and Koios Medical announce strategic partnership to integrate ProFound AI Breast Health Suite with Koios SmartUltrasound, creating a comprehensive AI-powered breast cancer detection solution.
iCad's AI-Powered Breast Cancer Detection Tech ProFound Detection version 4.0 Receives FDA Clearance
iCad's ProFound Detection version 4.0, an AI-powered solution for digital breast tomosynthesis (DBT), has received FDA clearance, marking a significant advancement in cancer detection technology.
iCAD's ProFound Detection 4.0 Receives FDA Clearance for Enhanced Breast Cancer Detection
iCAD's ProFound Detection Version 4.0, an AI-powered solution for digital breast tomosynthesis, has received FDA clearance, enhancing cancer detection and specificity.